Please login to the form below
Correction: Prexige suspended in UK, Germany and Austria
PMLive news article correction: Prexige suspended in UK, Germany and Austria
We would like to correct an article which appeared in the December 2007 issue of Pharmaceutical Marketing referring to the suspension of the arthritis drug Prexige (lumiracoxib).
In this article, we referred to this being a Bayer product; this is not the case. We would like to apologise to Bayer for our mistake and have corrected the story online.
The corrected story can be found here
Share
Related Hub content
COVID-19 Updates and Daily News
Featured jobs
- Senior Medical Writer, MedComms Agency
-
Salary TBC
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
-
Account Director, Medical Education
-
Salary TBC
-
Senior External Communications Lead
-
£Competitive Salary
- Account Director, Healthcare Communications
-
Salary TBC
- Senior Medical Writer or Lead Medical Writer
-
£Competitive Salary
-
Senior Medical Writer
-
Salary TBC
- Brand Manager - Medium Global Pharma Company
-
£Competitive Financial Package
-
Senior Account Manager
-
Salary TBC
-
Account Director – UK Office
-
Excellent salary and benefits
-
Account Manager (PR)
-
Great Benefits
-
Account Manager
-
£Competitive Salary
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Group Director of Medical Affairs and Scientific Strategy, Medic...
-
Substantial six figure package
-
Account Director
-
£Competitive Salary
- WHO partners with WhatsApp to provide accurate COVID-19 information
- UPDATED: Gilead drops remdesivir’s orphan drug designation
- FDA approves Roche’s Actemra COVID-19 trial
- Takeda begins development of COVID-19 plasma therapy
- UK, China prep trials of coronavirus vaccine candidates
- Did Trump offer CureVac $1bn for COVID-19 vaccine rights?
- COVID-19 delays Pfizer, Mylan’s generics merger and spin-out
- UK contributes £210m towards COVID-19 vaccine efforts
- Bluebird bio pushes back commercial launch of Zynteglo due to COVID-19
- In virtual meeting, CHMP backs Sanofi’s myeloma drug Sarclisa
- COVID-19 message to clients from OPEN Health CEO, David Rowley
- The march to sustainability
PMHub
Skills in Healthcare
At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...
Latest intelligence
- The role of women in science and technology
- Why the lack of female leaders in pharma and life sciences is a problem that still needs to be fixed...
- China’s homecoming heroes fuel a biotech boom with rapid CAR-T advances
- China secures a place at the forefront of innovative medicine...
- Virtual Research Grants Submission and Approval Program
- Impetus Digital summarizes how a client established an independent grant review committee and a virtual grant submission and approval program, without having to travel and meet in person....
Quick links
Infographics
